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Cancer Mortality in Four Northern Wheat-Producing States
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Chlorophenoxy herbicides such as 2,4-
dichlorophenoxyacetic acid (2,4-D) and 4-
chloro-2-methylphenoxyacetic acid (MCPA)
were ﬁrst produced after the Second World
War. They have been one of the most widely
used class of herbicides since the mid-1960s,
not only in the United States but also in
other parts of the world. They are used in
agriculture to control growth of broadleaf
weeds in cereal grains and in nonagricultural
settings to control growth of unwanted
brush in rangeland, forests, noncrop land,
rights-of-way, and in roadside maintenance.
In addition, 2,4-D is one of the most com-
monly used herbicides in urban areas for the
maintenance of parks, golf courses, play-
grounds, playing ﬁelds, and home lawns and
gardens (1–4). Chlorophenoxy herbicides
are often mixed with other herbicides and
fertilizer. Dioxins are unwanted contami-
nants (2,5–7). One of the most toxic diox-
ins, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), a contaminant of the chlorophe-
noxy herbicide 2,4,5-trichlorophenoxyacetic
acid (2,4,5-T), is a potent carcinogen in ani-
mals (6). Most registrations for 2,4,5-T were
canceled in 1979 by the U.S. Environmental
Protection Agency (2,6–8). Contamination
of 2,4-D and MCPA by TCDD is not likely
(5). More than 60% of all agricultural herbi-
cides used in the United States, including
2,4-D and MCPA, reportedly have the
potential to disrupt the endocrine and/or
reproductive system of animals (1).
Because chlorophenoxy herbicides are
among the most common herbicides, wide-
spread exposure to them is likely. Not only
are people working in the agricultural indus-
try exposed (e.g., farmers, farm workers, pes-
ticide manufacturers and mixers, and crop
duster pilots) but their families are also
exposed because of contaminated clothing or
dust tracked into the house (9). Lawn care
workers and highway maintenance workers
are also exposed. Other routes of exposure are
drift from aerial pesticide application to
crops, contamination of surface or ground-
water, or walking in recently sprayed lawns
and ﬁelds. A study of household pesticide use
observed that 2,4-D is one of the most preva-
lent herbicides used by home owners (1,10).
Suburban lawns and gardens probably receive
the heaviest applications of pesticides of any
land area in the United States (1,11). Home
owners may be less careful than farmers in
following instructions on the use of herbi-
cides and may apply more than is needed (3).
In contrast to most home owners, farmers are
knowledgeable about the chemicals they use
(12). Information on pesticide exposure
obtained from interviews of farmers is
thought to be reliable. Agricultural or season-
al workers, on the other hand, are not neces-
sarily informed about which chemicals they
are exposed to in the ﬁeld. 
Use of and exposure to chlorophenoxy
herbicides is widespread. Therefore, it may be
difﬁcult to ﬁnd a group of unexposed subjects
to be used as a referent in studies investigating
the effect of exposure to chlorophenoxy herbi-
cides on human health. However, it is possi-
ble to find regions with a gradient of low
and high exposures to chlorophenoxy herbi-
cides in wheat-growing states of the United
States. Most of the durum and spring wheat
(spring planted) grown in the United States
is produced in four states (93% in 1982):
Minnesota (MN), North Dakota (ND),
South Dakota (SD), and Montana (MT)
(13). Herbicide use on durum and spring
wheat is similar: > 90% of the acreage is treat-
ed with mostly chlorophenoxy herbicides
(2,4-D and MCPA). In contrast, only 30% of
the winter wheat acreage is usually treated
(14,15). The 1982 percentages of combined
spring and durum wheat acreage compared to
all wheat acreage in MN, MT, ND, and SD
were 97, 57, 98, and 65%, respectively (13). 
In the current study I used wheat acreage
per county as a surrogate for exposure to
chlorophenoxy herbicides because informa-
tion on crop acreage was more readily avail-
able than the amount of applied herbicides.
To study the effect of herbicide using crop
acreage as a surrogate, it is preferable that no
other herbicides are used on the same crop
and that no other crops are treated with the
same herbicides. Agriculture in MN, ND,
SD, and MT approaches this ideal situation
because these four states grow few crops
[wheat, corn, and soybeans are the main crops
(Table 1)] and only have one crop season.
Chlorophenoxy herbicides are used on wheat
but not on soybeans, and little is used on corn
(14,15). Barley, grown in the same regions as
wheat, is also treated with chlorophenoxy her-
bicides. Because the wheat acreage in these
four states is approximately 4–5 times larger
than the barley acreage, I used wheat acreage
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Chlorophenoxy herbicides are used both in cereal grain agriculture and in nonagricultural settings
such as right-of-ways, lawns, and parks. Minnesota, North Dakota, South Dakota, and Montana
grow most of the spring and durum wheat produced in the United States. More than 90% of
spring and durum wheat is treated with chlorophenoxy herbicides, in contrast to treatment of
approximately 30% of winter wheat. In this ecologic study I used wheat acreage as a surrogate for
exposure to chlorophenoxy herbicides. I investigated the association of chlorophenoxy herbicides
with cancer mortality during 1980–1989 for selected counties based on level of agriculture
(≥ 20%) and rural population (≥ 50%). Age-standardized cancer mortality rates were determined
for grouped counties based on tertiles of wheat acreage per county or for individual counties for
frequently occurring cancers. The cancer sites that showed positive trends of increasing cancer
mortality with increasing wheat acreage were esophagus, stomach, rectum, pancreas, larynx,
prostate, kidney and ureter, brain, thyroid, bone, and all cancers (men) and oral cavity and tongue,
esophagus, stomach, liver and gall bladder and bile ducts, pancreas, cervix, ovary, bladder, and
other urinary organs, and all cancers (women). Rare cancers in men and women and cancers in
boys and girls were studied by comparing counties above and below the median of wheat acreage
per county. There was increased mortality for cancer of the nose and eye in both men and women,
brain and leukemia in both boys and girls, and all cancers in boys. These results suggest an associa-
tion between cancer mortality and wheat acreage in counties of these four states. Key words: adults,
agriculture, cancer mortality, children, chlorophenoxy herbicides, 2,4-D, herbicides, human,
MCPA, pesticides, wheat. Environ Health Perspect 108:873–881 (2000). [Online 1 August 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p873-881schreinemachers/abstract.html
Articlesas a measure of exposure to chlorophenoxy
herbicides. Estimates of the wheat acreage by
county were obtained from the 1982
Agricultural Census conducted by the U.S.
Department of Agriculture (USDA) (16). 
In a previous study Schreinemachers et
al. (17) reported excess mortality in North-
western Minnesota during 1980–1989 for
cancer of the prostate, thyroid, and bone in
men and for cancer of the eye in women.
This region has a high level of agriculture:
most of the available land is used to grow
spring wheat. The objective of the current
study was to confirm the previous results
using a larger data set by including addition-
al states and conduct more detailed analyses. 
Materials and Methods
Cancer mortality. Cancer mortality data
(underlying cause of death) for 1980–1989
collected by the National Center for Health
Statistics (18) were summarized for 34 cancer
groups by 5-year age intervals, sex, race, and
county and state of residence based on meth-
ods used by the National Cancer Institute to
summarize cancer mortality data for previous
decades. (19). Estimates for the population at
risk during 1980–1989 by 5-year age groups,
sex, race, and county and state of residence
for non-Census years were obtained by inter-
polation between the 1980 and 1990 Census
population estimates (20,21) and by sum-
ming these estimates for 1980–1989. 
Crop acreage. The 1982 USDA Agri-
cultural Census database (16) provided
information on acreage of total land area,
total crop land, and individual harvested
crop acreage by county. Although most of
the wheat grown in MN, ND, SD, and MT
was spring or durum wheat, some of the
acreage was winter wheat. Because this data-
base did not distinguish between acres of
winter, durum, and spring wheat by county,
I used total wheat acreage as a surrogate for
chlorophenoxy herbicide exposure. For a few
counties with very low levels of wheat agri-
culture in 1982, the harvested wheat acreage
was withheld to avoid disclosing data for
individual farms, although the number of
farms was listed. Estimates were obtained by
multiplying the number of farms with the
average wheat acreage per farm from the
1987 Agricultural Census (16). 
Statistical methods. I excluded counties
with < 20% crop land (i.e., total land area
dedicated to crop land) or with an urban
population of > 50% from the analyses.
These exclusions were made to ensure that
risk estimates would reﬂect rural populations
which are more likely to be exposed to agri-
cultural pesticides than urban populations. I
divided the remaining counties (≥ 20% crop
land and ≥ 50% rural population) into three
groups based on tertiles of wheat acreage per
county as estimated by the 1982 USDA
Agricultural Census (16). I calculated age-
standardized mortality rate ratios (SRRs)
comparing the second and third tertile to the
ﬁrst tertile for each cancer site for men and
women ≥ 15 years of age. SRRs for a cancer
site were calculated only if each of the two
groups being compared included at least ﬁve
deaths. Only white subjects were included
because data for nonwhites were too sparse to
allow for reliable analysis. SRRs for rare can-
cers in men and women and cancers in boys
and girls (< 15 years of age) were calculated
by dividing counties into two groups based
on the median of wheat per county, provided
at least five deaths were reported for each
group. The 1970 U.S. population was used
for the age standardization using the direct
method (22). Conﬁdence intervals (95%) for
the SRRs were calculated based on a Poisson
model using a method described by
Rothman and Greenland (22). 
In addition to analyses for grouped
counties, I also investigated the more fre-
quently occurring cancers using individual
counties as the unit of observation. Kendall’s
rank correlation was used as a measure of
association between wheat acreage and age-
standardized cancer mortality rates by coun-
ty. Counties reporting less than ﬁve deaths
were excluded. For selected cancer sites these
signiﬁcant associations were further illustrat-
ed by plotting age-adjusted cancer mortality
rates versus the logarithm (base 10) of wheat
acreage per county. A smooth line was ﬁtted
using a spline routine. 
For those cancer sites showing a positive
trend with increasing wheat acreage, a signif-
icantly increased mortality for at least one of
the two higher tertiles of combined counties,
or a positive correlation with wheat acreage
per county, I calculated SRRs separately for
age groups < 65 and ≥ 65 years of age for
both sexes. 
I used SAS software (23) for all statistical
analyses. 
Results
The distribution of harvested crops by state
according to the 1982 Agricultural Census is
presented in Table 1. Most of the available
crop land in MN, MT, ND, and SD is used
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Table 1. Percent harvested crop of total crop land.a
Minnesota North Dakota South Dakota Montana 
Total crop land (acres × 106) 22.2 28.1 18.8 16.5
Harvested crop land (%) 88.9 72.2 76.6 56.9
Wheat 13.4 34.9 17.7 31.7
Corn 26.6 1.9 13.7 0.1
Soybeans 20.3 1.5 4.1 NA
Barley 3.7 6.4 2.8 9.8
Oats 5.8 3.4 9.6 1.0
Potatoes 0.4 0.4 NA NA
Sugar beets 1.2 0.5 NA 0.2
Hay 11.3 9.4 20.1 13.6
Sunﬂower seeds 2.1 11.1 2.6 NA
Average farm size (acres) 294 1,104 1,179 2,568
Data from the 1982 Agricultural Census (16). NA, not available.
Table 2. Characteristics of three groups of combined counties based on wheat acreage. 
Wheat acreage per county 
Characteristics < 23,000 23,000–110,999  ≥ 111,000
Number of counties 
Minnesota 33 16 7
North Dakota 0 10 30
South Dakota 17 21 3
Montana 0 4 11
Total 50 51 51
Land
Approximate land area, acres ×  106 (%) 19.5 (100) 35.3 (100) 50.4 (100)
Total crop land, acres × 106 (%) 12.1 (62) 16.5 (47) 29.0 (58)
Harvested crop land, acres × 106 (%) 10.5 (100) 12.9 (100) 20.2 (100)
Wheat, acres × 106 (%) 0.3 (3) 3.6 (28) 10.6 (53)
Corn, acres × 106 (%) 4.1 (39) 2.0 (16) 0.6 (3)
Soybeans, acres × 106 (%) 2.4 (23) 1.5 (11) 0.4 (2)
Average size of annual population at risk
Men 454,149 203,944 174,945
Women 459,225 205,598 172,397
Population ≥ 65 years of age (%) 14.6 17.8 17.6
Rural population (%) 72 79 84
Living on farm (%) 20 26 26
Average farm size (acres) 300 889 1,221
Average 1979 median family income 15,821 14,428 15,665for the agriculture of wheat, corn, soybeans,
and hay. 
Among the 262 counties in MN, ND,
SD, and MT, 110 counties (42%) were
excluded from the analyses because they had
< 20% crop land and/or had a rural popula-
tion of < 50%. These counties were located in
the Rocky Mountains of MT; rangeland
regions of MT, ND, and SD; forested and
wetland regions of MN; and urban regions in
each of the four states. The remaining 152
counties were divided into three groups based
on tertiles of wheat acreage per county
(< 23,000; 23,000–110,999; and ≥ 111,000).
The median, minimum, and maximum were
72,000, 135, and 453,148 acres per county,
respectively. Characteristics for the three
groups of counties are presented in Table 2.
Several differences were observed. Counties in
the lowest wheat category were located in
MN and SD; counties in the highest wheat
category were located mostly in ND and MT.
Average county and farm size and percentages
of rural and farm population increased with
increasing wheat acreage per county; average
population-at-risk decreased. The population
in counties with < 23,000 acres of wheat was
slightly younger than in the two other groups
of counties. 
Age-adjusted cancer mortality rates per
100,000 and rate ratios comparing counties
with 23,000–110,999 and ≥ 111,000 acres
of wheat to counties with < 23,000 acres of
wheat are presented in Table 3 (men) and
Table 4 (women) ≥ 15 years of age. In gen-
eral, men showed higher cancer mortality
rates than women. Increasing cancer rates for
the three tertiles of counties, or a statistically
signiﬁcant increased rate for either the sec-
ond or the third tertile of counties, were
observed for the following cancer sites: sali-
vary gland, esophagus, rectum, pancreas, lar-
ynx, prostate, kidney, thyroid, bone and jaw,
Hodgkin disease, and all cancers (men); oral
cavity and tongue, esophagus, stomach, rec-
tum, liver and gall bladder and bile ducts,
pancreas, cervix, bladder, and other urinary
organs, secondary or unspecified sites, and
all cancers (women). It is conceivable that
stronger effects would have been obtained if
the referent group had been composed of
counties with a smaller wheat acreage, e.g.,
10,000 acres per county. The use of grouped
counties based on tertiles of wheat acreage
per county, as presented in Tables 3 and 4,
was a more conservative approach. 
Table 5 presents mortality for men and
women from rare cancers and cancer mortal-
ity in boys and girls. There was increased
cancer mortality for nose and eye cancer in
both men and women and brain cancer and
leukemia in both boys and girls. Mortality
from all cancers was also increased in boys.
None of these increased cancer rates were
statistically significant except cancer of the
eye among women (borderline signiﬁcant).
Mortality from cancers of the eye, nose and
nasal cavity, and oral cavity were increased in
high wheat-producing counties. These can-
cer sites may represent mucosa exposed to
aerially applied pesticides.
Table 6 presents correlations between age-
standardized cancer mortality rates and wheat
acreage per county for cancers with > 400
deaths reported for the combined 152 coun-
ties during 1980–1989. I excluded counties
with less than ﬁve deaths for the cancer being
analyzed. Statistically signiﬁcant correlations
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Table 3. Age-standardized cancer mortality rates and ratios for white men, 1980–1989. 
Wheat acreage per county 
< 23,000 23,000–110,999 ≥ 111,000 
Cancer site (ICD-9 code) n Rate n Rate SRR (CI) n Rate SRR (CI) 
Salivary gland (142) 6 0.13 12 0.53 3.96 (1.47–10.67) 5 0.28 2.08 (0.62–6.94)
Oral cavity including tongue (141, 143–146, 111 3.08 60 2.90 0.94 (0.68–1.30) 55 3.34 1.08 (0.78–1.51)
148, 149)
Esophagus (150) 212 5.66 116 5.74 1.01 (0.80–1.28) 103 5.87  1.04 (0.82–1.32)
Stomach (151) 404 10.23 221 10.05 0.98 (0.83–1.16) 199 10.59 1.04 (0.87–1.23)
Large intestine (153, 159) 1,070 26.82 599 27.43 1.02 (0.92–1.13) 494 26.23 0.98 (0.88–1.09)
Rectum (154 excluding 154.3) 186 4.75 103 4.94 1.04 (0.81–1.33) 117 6.26 1.32 (1.04–1.67)
Liver, gallbladder including bile ducts 179 4.62 112 5.48 1.19 (0.93–1.51) 100 5.23 1.13 (0.88–1.45)
(155, 156)
Pancreas (157) 453 11.78 266 12.82 1.09 (0.93–1.27) 270 14.53 1.23 (1.06–1.44)
Larynx (161) 67 1.75 39 1.95 1.12 (0.75–1.67) 48 2.69 1.54 (1.06–2.25)
Trachea, bronchus, lung 2,499 66.69 1,355 66.24 0.99 (0.93–1.06) 1,169 66.25 0.99 (0.93–1.07)
(162, 163, 165)
Prostate (185) 1,368 31.12 836 34.24 1.10 (1.01–1.20) 808 38.64 1.24 (1.14–1.36)
Kidney, ureter (189, excluding 189.3) 272 7.04 147 7.10 1.01 (0.82–1.24) 129 7.28 1.03 (0.83–1.28)
Bladder, other urinary organs (188, 189.3) 306 7.19 147 6.07 0.84 (0.69–1.03) 129 6.36 0.88 (0.72–1.09)
Malignant melanoma (172) 121 3.39 50 2.67 0.79 (0.56–1.11) 41 2.68 0.79 (0.55–1.14)
Nonmelanoma skin (173, 154.3) 54 1.26 28 1.24 0.98 (0.61–1.57) 24 1.25 0.99 (0.60–1.62)
Brain, other parts of nervous system 264 7.48 131 6.96 0.93 (0.75–1.15) 130 8.16 1.09 (0.88–1.35)
(191, 192)
Thyroid (193) 10 0.27 9 0.39 1.45 (0.58–3.63) 10 0.51 1.88 (0.76–4.62)
Thymus and other endocrine glands 11 0.32 5 0.26 0.82 (0.28–2.42) 8 0.45 1.42 (0.56–3.59)
(194, 164.0)
Bone including jaw (170) 19 0.56 12 0.66 1.18 (0.56–2.47) 16 1.08 1.94 (0.98–3.84)
Connective and soft tissue (171, 164.1) 51 1.37 20 1.00 0.73 (0.43–1.24) 24 1.45 1.06 (0.64–1.75)
Hodgkin disease (201) 38 1.01 32 1.81 1.80 (1.11–2.92) 14 0.80 0.80 (0.43–1.49)
Lymphosarcoma, reticulum cell sarcoma 418 10.83 186 8.82 0.81 (0.68–0.97) 176 9.68 0.89 (0.75–1.07)
including other lymphoma (159.1, 200, 
202.0, 202.1, 202.8, 202.9)
Multiple myeloma (203, excluding 203.1) 197 4.96 108 4.95 1.00 (0.78–1.27) 75 3.89 0.79 (0.60–1.03)
Leukemia (204–208, 202.4, 203.1) 471 11.90 246 11.60 0.97 (0.83–1.14) 248 13.25 1.11 (0.95–1.30)
Secondary, site unspeciﬁed, not previously 579 14.67 331 15.77 1.07 (0.94–1.23) 224 11.95 0.81 (0.70–0.95)
listed (152, 158, 159.2–159.9, 164.2–164.9)
All cancers (140–208) 9,442 240.88 5,205 243.23 1.01 (0.98–1.05) 4,639 250.05 1.04 (1.00–1.08)
ICD-9, International Classiﬁcation of Diseases, 9th Revision (World Health Organization, Geneva). Comparison of grouped counties based on tertiles of wheat acreage per county. Rates
per 100,000 are age-adjusted and are calculated only if at least ﬁve deaths are reported in each of the two groups being compared. The average annual population at risk for combined
counties with < 23,000, 23,000–110,999, and ≥ 111,000 acres of wheat was 338,471, 155,468, and 134,419, respectively. Bold text indicates increasing cancer rates for the three tertiles of
counties or a statistically signiﬁcant increased rate for either the second or the third tertile of counties. were observed for the following sites: stom-
ach, rectum, pancreas, prostate, brain, and
leukemia (men); stomach, pancreas, ovary,
and secondary and unspecified cancers
(women). Figure 1A–F illustrates cancer mor-
tality rates and wheat acreage by county for
some of these results: pancreas, prostate, and
leukemia in men and pancreas, ovary, and
secondary and unspeciﬁed sites in women.
Those cancer sites showing a trend of
increasing cancer mortality with increasing
wheat acreage for the three groups of coun-
ties, a statistically signiﬁcant increase in either
the second or third tertile of grouped coun-
ties (Tables 3 and 4), or a signiﬁcant correla-
tion between cancer mortality and wheat
acreage per county (Table 6), were further
analyzed by age (< 65 and ≥ 65 years of age),
as presented in Tables 7 and 8 for men and
women, respectively. If an effect was
observed for all ages for only one of the sexes,
the analyses by age group were still done for
both sexes so that mortality rates for the same
cancer sites could be compared between men
and women. Subjects ≥ 65 years of age had
higher rates than those < 65 years of age.
Many of the trends showing increased cancer
mortality with increasing wheat acreage
[observed for all ages (Tables 3 and 4)] were
also observed for one or both age groups
(Tables 7 and 8): salivary gland (men ≥ 65),
oral cavity including tongue (women < 65
and ≥ 65), stomach (women < 65), rectum
(men ≥ 65), pancreas (men ≥ 65; women
< 65 and ≥ 65), cervix uteri (women < 65),
prostate (men < 65 and ≥ 65), kidney and
ureter (men < 65), bladder and other urinary
organs (women ≥ 65), thyroid (men, ≥ 65;
women ≥ 65), bone (men < 65 and ≥ 65),
and Hodgkin disease (men < 65 and ≥ 65;
women ≥ 65). Trends for thyroid cancer and
Hodgkin disease were observed for women
≥ 65 years of age, although no effect was seen
for women of all ages (Tables 4 and 8).
Although cancer mortality rates were general-
ly higher in men for either age group, women
≥ 65 years of age had a higher rate for thyroid
cancer mortality then men of the same age.
For other sites showing trends of increasing
mortality rates for all ages, like larynx in men
and esophagus, rectum, liver, and secondary
and unspecified sites in women, the trend
was not observed for either age group,
although increased rates were observed for
either one of the two higher wheat groups,
some of which were statistically signiﬁcant.
A previous study (17) reported signifi-
cantly increased cancer mortality in
Northwestern MN for prostate, thyroid,
and bone for men and eye for women. The
comparison region in that study was the
urban/forested region of MN. To ensure
that MN was not driving the results in the
current study, I calculated the SRRs for
these four cancer sites separately for MN and
combined ND, SD, and MT and compared
counties with ≥ 72,000 acres of wheat to
counties with < 72,000 acres. The SRRs for
MN and combined ND, SD, and MT,
respectively, for men were prostate, 1.14
(CI, 1.00–1.30) and 1.23 (CI, 1.07–1.41)
and bone, 2.79 (CI, 1.09–7.15) and 1.82
(CI, 0.66–4.99). Because only two deaths
were reported for cancer of the thyroid in
men and eye cancer in women for the refer-
ent group of combined counties in MT,
ND, and SD, I did not calculate SRRs for
these two cancer sites. These numbers are
probably low because these two cancers are
rare and the population size of combined
ND, SD, and MT is low (less than half of
the MN population). The results for prostate
and bone cancer mortality do not indicate
that MN is driving the results.
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Table 4. Age-standardized cancer mortality rates and ratios for white women, 1980–1989. 
Wheat acreage per county 
< 23,000 23,000–110,999 ≥ 111,000 
Cancer site (ICD-9 code) n Rate n Rate SRR (CI) n Rate SRR (CI) 
Oral cavity including tongue (141, 143–146,  37 0.67 24 0.87 1.30 (0.73–2.29) 27 1.32 1.96 (1.14–3.38)
148, 149)
Esophagus (150) 58 1.06 34 1.11 1.05 (0.67–1.64) 27 1.17 1.11 (0.67–1.83)
Stomach (151) 240 4.20 127 4.39 1.05 (0.82–1.33) 125 5.61 1.34 (1.05–1.70)
Large intestine (153, 159) 1,070 19.87 601 21.13 1.06 (0.95–1.19) 472 19.75 0.99 (0.88–1.12)
Rectum (154 excluding 154.3) 131 2.19 89 3.00 1.37 (1.02–1.84) 61 2.46 1.12 (0.81–1.57)
Liver, gallbladder including bile ducts (155, 156) 241 4.65 126 4.72 1.01 (0.80–1.28) 127 5.51 1.19 (0.94–1.49)
Pancreas (157) 454 8.54 259 9.61 1.13 (0.95–1.33) 241 10.55 1.24 (1.04–1.46)
Trachea, bronchus, lung (162, 163, 165) 889 20.97 433 19.31 0.92 (0.81–1.04) 420 22.15 1.06 (0.93–1.19)
Breast (174, 175) 1,578 36.23 818 35.62 0.98 (0.90–1.08) 661 35.52 0.98 (0.89–1.08)
Cervix uteri (180) 82 2.02 40 2.21 1.09 (0.73–1.64) 50 3.09 1.53 (1.05–2.22)
Chorion, uterus (179, 181, 182) 249 4.79 123 4.81 1.00 (0.80–1.27) 95 4.37 0.91 (0.71–1.18)
Ovary, fallopian tube, broad ligament (183) 511 11.27 246 10.28 0.91 (0.78–1.07) 230 11.95 1.06 (0.90–1.25)
Kidney, ureter (189, excluding 189.3) 177 3.86 85 3.42 0.89 (0.67–1.17) 90 4.13 1.07 (0.82–1.40)
Bladder, other urinary organs (188, 189.3) 123 1.96 67 2.14 1.10 (0.79–1.51) 59 2.21 1.13 (0.80–1.58)
Malignant melanoma (172) 85 1.99 59 2.44 1.22 (0.85–1.76) 29 1.48 0.74 (0.47–1.16)
Nonmelanoma skin (173, 154.3) 27 0.43 9 0.36 0.85 (0.36–2.01) 13 0.54 1.27 (0.60–2.70)
Brain, other parts of nervous system 189 4.66 94 4.45 0.95 (0.73–1.24) 95 5.39 1.16 (0.89–1.50)
(191, 192)
Thyroid (193) 25 0.49 12 0.38 0.78 (0.38–1.62) 13 0.45 0.93 (0.45–1.90)
Bone including jaw (170) 22 0.54 8 0.36 0.66 (0.27–1.63) 11 0.64 1.19 (0.53–2.69)
Connective and soft tissue 56 1.28 38 1.65 1.29 (0.82–2.01) 27 1.58 1.23 (0.75–2.02)
(171, 164.1)
Hodgkin disease (201) 29 0.72 19 0.74 1.03 (0.55–1.94) 14 0.62 0.86 (0.43–1.69)
Lymphosarcoma, reticulum cell sarcoma  389 7.71 202 7.41 0.96 (0.80–1.16) 162 7.32 0.95 (0.78–1.16)
including other lymphoma (159.1, 200, 
202.0, 202.1, 202.8, 202.9)
Multiple myeloma (203, excluding 203.1) 171 3.47 91 3.46 1.00 (0.76–1.31) 77 3.35 0.97 (0.72–1.29)
Leukemia (204–208, 202.4, 203.1) 373 7.20 183 6.81 0.95 (0.78–1.15) 146 6.70 0.93 (0.76–1.15)
Secondary, site unspeciﬁed, not previously  555 10.53 350 12.48 1.19 (1.02–1.37) 268 11.71 1.11 (0.95–1.30)
listed (152, 158, 159.2–159.9, 164.2–164.9)
All cancers (140–208) 7,824 162.65 4,161 164.44 1.01 (0.97–1.05) 3,574 171.34 1.05 (1.01–1.10)
ICD-9, International Classiﬁcation of Diseases, 9th Revision (World Health Organization, Geneva). Comparison of grouped counties based on tertiles of wheat acreage per county. Rates
per 100,000 are age-adjusted and are calculated only if at least ﬁve deaths are reported in each of the two groups being compared. The average annual population at risk for combined
counties with < 23,000, 23,000–110,999, and ≥ 111,000 acres of wheat was 349,660, 160,200, and 134,105, respectively. Bold text indicates increasing cancer rates for the three tertiles of
counties or a statistically signiﬁcant increased rate for either the second or the third tertile of counties. Discussion
This ecologic study investigated cancer mor-
tality rates in counties of MN, ND, SD, and
MT, where the population was mostly rural
and where at least 20% of the available land
was dedicated to crop land. Because of these
inclusion criteria, the percentage of rural and
farm population was higher in this study pop-
ulation of 152 counties than if all 262 counties
had been included. The study population of
the combined 152 counties can be categorized
as follows: rural and living on farms, 23%;
rural not living on farms, 54%; and nonrural,
23%. For the combined 262 counties these
percentages would have been as follows: rural
and living on farms, 10%; rural not living on
farms, 29%; and nonrural, 61%. It is conceiv-
able that the “rural not living on farms” popu-
lation included people working on a farm.
Because occupational information was not
available for this mortality dataset, it was not
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Table 5. Mortality rates and ratios during 1980–1989 for rare cancers in white men and women and cancers in white boys and girls. 
Wheat acreage/county 
< 72,000 ≥ 72,000 
Cancer site (ICD-9 code) n Rate n Rate SRR (CI)
Men
Nose, nasal cavities, middle ear, accessory sinuses (160) 16 0.29 11 0.44 1.49 (0.67–3.31)
Breast (174, 175) 16 0.29 7 0.26 0.89 (0.36–2.19)
Eye (190) 8 0.15 7 0.30 1.95 (0.69–5.47)
Women
Salivary gland (142) 17 0.28 6 0.16 0.58 (0.20–1.62)
Nose, nasal cavities, middle ear, accessory sinuses (160) 15 0.20 8 0.37 1.81 (0.72–4.55)
Eye (190) 9 0.13 9 0.36 2.77 (1.00–7.63)
Thymus and other endocrine 16 0.31 9 0.33 1.07 (0.45–2.56)
glands (194, 164.0)
Boys
Brain, other parts of nervous system (191, 192) 13 0.87 9 1.58 1.82 (0.78–4.26)
Leukemia (204–208, 202.4, 203.1) 29 1.92 15 2.69 1.40 (0.75–2.62)
All cancers (140–208) 67 4.46 34 6.14 1.38 (0.91–2.08)
Girls
Brain, other parts of nervous system (191, 192) 8 0.59 5 0.96 1.63 (0.53–4.99)
Leukemia (204–208, 202.4, 203.1) 10 0.69 5 0.98 1.43 (0.49–4.18)
All cancers (140–208) 38 2.68 14 2.73 1.02 (0.55–1.88)
ICD-9, International Classiﬁcation of Diseases, 9th Revision (World Health Organization, Geneva). Comparison of grouped counties based on the median of wheat acreage per county.
Rates per 100,000 are age-adjusted, and are calculated only if at least ﬁve deaths are reported in each of the two groups being compared. The average annual population-at-risk for
combined counties with < 72,000 and ≥ 72,000 acres of wheat were 447,300 and 181,058, respectively (men); 462,676 and 181,289, respectively (women); 149,973 and 54,707, respectively
(boys); and 141,707 and 51,548, respectively (girls). 
Table 6. Mortality for frequent cancers during 1980–1989. 
Cancer Kendall’s tau-b 
Cancer site (ICD-9 code)  Counties (n) deaths(n) coefﬁcient  p-Value
Men
Esophagus (150) 32 257 0.10 0.43
Stomach (151) 68 656 0.28 0.0008
Large intestine (153, 159) 125 2,093 0.01 0.90
Rectum (154 excluding 154.3) 29 223 0.32 0.016
Pancreas (157) 81 829 0.32 0.0001
Trachea, bronchus, lung (162, 163, 165) 146 5,004 –0.07 0.21
Prostate (185) 131 2,959 0.22 0.0002
Kidney, ureter (189, excluding 189.3) 43 358 0.09 0.40
Bladder, other urinary organs (188, 189.3) 44 373 0.04 0.69
Brain, other parts of nervous system (191, 192) 48 379 0.21 0.03
Lymphosarcoma, reticulum cell sarcoma including other 61 623 0.07 0.40
lymphoma (159.1, 200, 202.0, 202.1, 202.8, 202.9)
Leukemia (204–208, 202.4, 203.1) 82 861 0.27 0.0003
Secondary, site unspeciﬁed, not previously listed (152, 158, 88 1,023 0.02 0.82
159.2–159.9, 164.2–164.9)
All cancers (140–208) 152 19,387 0.05 0.39
Women
Stomach (151) 40 314 0.26 0.02
Large intestine (153, 159) 117 2,062 0.02 0.76
Liver, gallbladder including bile ducts (155, 156) 38 314 0.19 0.08
Pancreas (157) 76 794 0.26 0.001
Trachea, bronchus, lung (162, 163, 165)  109 1,634 0.10 0.14
Breast (174, 175) 132 3,007 0.00 0.96
Ovary, fallopian tube, broad ligament (183) 70 811 0.18 0.03
Lymphosarcoma, reticulum cell sarcoma including other 63 589 0.13 0.12
lymphoma (159.1, 200, 202.0, 202.1, 202.8, 202.9) 
Leukemia (204–208, 202.4, 203.1) 63 566 0.16 0.07
Secondary, site unspeciﬁed, not previously listed (152, 158, 92 1,051 0.19 0.006
159.2–159.9, 164.2–164.9)
All cancers (140–208) 150 15,606 0.08 0.14
ICD-9, International Classiﬁcation of Diseases, 9th Revision (World Health Organization, Geneva). Correlations between age-standardized cancer rates and wheat acreage by county. possible to check how many of the cancer
deaths could be attributed to farmers and
other agricultural workers. Although people
living or working on a farm most likely have
the highest exposures to pesticides, rural peo-
ple not living or working on a farm may be
exposed to drift of aerially applied pesticides
or through their well water.
Residents of counties where the main
crop was spring or durum wheat were at an
increased mortality risk for several types of
cancer. This gave rise to the question of
whether other factors associated with wheat
could have played a role. Percent rural and
farm population and average farm size were
associated with wheat acreage (Table 2). The
correlation coefﬁcients for wheat acreage per
county with percent rural and farm popula-
tion were 0.23 (p = 0.0001) and 0.13 (p =
0.02), respectively. Average farm size per
county was correlated with wheat acreage
(correlation coefﬁcient = 0.47, p = 0.0001).
We would expect farms to be large when large
plots of land are available for wheat agricul-
ture in these regions. In other words, farm
size may be a consequence of land available
for wheat agriculture. Farmers are generally
exposed to a variety of hazardous substances
such as pesticides, fuels, oils, engine exhausts,
and organic solvents (12). Farm families liv-
ing on large farms have potentially higher
exposures to these compounds than families
living on small farms. Methods of pesticide
application may also be different on large
farms. Age is a risk factor for cancer mortality.
People living in counties with > 23,000 acres
of wheat were slightly older than subjects 
living in counties with less wheat (Table 2). I
used age standardization in the analyses to
adjust for these differences. Another factor to
be considered is delayed diagnosis, which
may occur among the rural population
because of long distances from medical facili-
ties. In that case, we would expect increased
mortality for all cancer sites. This was not
observed in the current study. 
This study had other limitations. The use
of wheat acreage as a surrogate measure of
exposure to chlorophenoxy herbicides was a
major disadvantage because it provided no
information on when and how often expo-
sures occurred. Migration into or out of
counties was unknown, although residential
stability in farming communities tends to be
higher than in urban communities (12).
Individual information on smoking, alcohol
use, and ethnic background was not available. 
Smoking-related cancers (lung, larynx,
oral cavity, esophagus, and bladder) are
increased in urban populations and decreased
in farmers (9,12,24,25). Mortality rates for
these cancer sites for the 60 counties that
were excluded from the analyses because of
their mostly urban population conﬁrmed this
finding. Using the same referent group of
rural counties as in Tables 3 and 4 (< 23,000
acres of wheat per county), age-standardized
rates per 100,000 and SRR (CI) were
obtained for the combined 60 urban counties
as follows: 
• Trachea and bronchus and lung—men:
rate = 84.13, SRR = 1.26 (CI, 1.21–1.32);
women: rate = 31.52, SRR = 1.50 (CI,
1.39–1.62) 
• Larynx—men: rate = 3.02, SRR = 1.73
(CI, 1.33–2.25); women: rate = 0.49, SRR
= 1.52 (CI, 0.83–2.78) 
• Oral cavity—men: rate = 4.80, SRR = 1.56
(CI, 1.27–1.92); women: rate = 1.72, SRR
= 2.55 (CI, 1.75–3.71) 
• Esophagus—men: rate = 7.04, SRR = 1.24
(CI, 1.07–1.45); women: rate = 1.65, SRR
= 1.55 (CI, 1.15–2.11) 
• Bladder—men: rate = 8.19, SRR = 1.14
(CI, 1.00–1.30); women: rate = 2.31, SRR
= 1.18 (CI, 0.95–1.46). 
In the current study with a mostly rural popu-
lation, there was increased mortality for some
of these same cancer sites in counties with
higher wheat acreage: oral cavity (women)
and larynx (men) were signiﬁcantly increased;
there were nonsigniﬁcant increases for esoph-
agus and bladder (Tables 3 and 4). Because
there was no effect for lung cancer and
because there is no reason to suspect that
smoking would be related to acres of wheat
grown, the increases observed for these cancer
sites might be related to herbicide exposure.
However, increased lung cancer mortality in
association with pesticide exposure cannot be
ruled out. An increase of lung cancer mortali-
ty was observed for Florida pest control work-
ers with increasing duration of licensure after
adjusting for smoking (26). These subjects
were exposed to several pesticides, including
phenoxyacetic acids. This Florida study (26)
illustrates the need to adjust for smoking
when lung cancer in farmers, which may be
associated with pesticide exposure, is com-
pared to lung cancer in an urban population,
which is mostly smoking related (27). In the
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Figure 1. Age-standardized mortality rates per 100,000 during 1980–1989, for counties of MN, MT, ND, and SD, excluding counties reporting less than ﬁve deaths
for the cancer site. Rates for adults 15–85+ years of age. (A) Cancer of the pancreas (men). (B) Cancer of the prostate (men). (C) Leukemia (men). (D) Cancer of
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Fcurrent study the percent rural population
for the referent group (72%) was lower than
for the two other groups of counties
(23,000–110,999 and ≥ 111,000 acres of
wheat; 79 and 84%, respectively). It is con-
ceivable that lung cancer mortality in the
referent group is associated with smoking
because of its larger percentage of nonrural
population (38%), whereas lung cancer
mortality in the two more rural groups of
counties may be associated with higher her-
bicide exposure. If this were the case, the
potential effect from herbicide exposure on
lung cancer mortality could only be studied
in these data if smoking information were
available.
Because this is an ecologic study, there is
the possibility of an ecologic fallacy, which
occurs when the association observed for
counties or groups of counties does not hold
for individuals (8,11,28,29). However, eco-
logic studies do have some advantages. The
current study was based on existing databas-
es and included a large number of observa-
tions. Therefore, besides being relatively
inexpensive, this study allowed investigation
of rare cancers and analyses for trends.
Results from this study will generate
hypotheses for more resource-intensive and
definitive cohort and case–control studies
where exposure information can be deter-
mined for individual subjects, thereby avoid-
ing ecologic fallacies.
Although some of the results in the cur-
rent study were undoubtedly due to chance,
the fact that trends of increased mortality
rates were observed with increasing wheat
acreage for several cancer sites strengthens the
likelihood of an association. In addition, these
results should be considered in conjunction
with other studies. Many of the same cancer
sites increased in the current study have been
reported as being increased both in farmers in
general and in production workers occupa-
tionally exposed to chlorophenoxy herbicides
and their contaminants (6,9,12,24,30–35). In
a review of cancer etiology in farmers, Blair et
al. (30) noted that several cancers with exces-
sive rates among farmers have also been on
the rise in the general population. Therefore,
studies of farmers, who have generally better
defined and higher exposures to farm
chemicals than the general population, might
contribute to an explanation for these increas-
es. Excess mortality from several cancers was
observed for farmers—Hodgkin disease;
non-Hodgkin lymphoma; multiple myelo-
ma; leukemia; melanoma; other skin cancer;
and cancers of the lip, eye, stomach, rectum,
brain, connective and soft tissue, pancreas,
kidney, bone, thyroid, prostate, and testis
(9,12,24,30–33). In a cancer incidence study
of Florida pesticide applicators, statistically
signiﬁcant increases were observed for cancer
of the prostate, testis, and cervix (34). In a
cancer mortality study of Florida pesticide
applicators by the same authors, statistically
significant increases were observed for
prostate cancer only (35). Among children,
leukemia and brain tumors are common
malignancies that have been associated with
pesticide exposure of the parents or the chil-
dren themselves (9,11,36,37). Some of the
increases may be explained by factors other
than farm chemicals. For example, farmers
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Table 7. Age-standardized cancer mortality rates and ratios for selected cancer sites for white men < 65 and ≥ 65 years of age, 1980–1989. 
Wheat acreage/county 
< 23,000 23,000–110,999 ≥ 111,000 
Cancer site (ICD-9 code) Age (years) n Rate n Rate SRR (CI) n Rate SRR (CI) 
Salivary gland (142) ≥ 65 6 0.97 11 3.36 3.46 (1.27–9.44) ND – –
Oral cavity including tongue < 65 50 1.90 20 1.42 0.75 (0.44–1.26) 24 2.07 1.09 (0.67–1.79)
(141,143–146, 148, 149) ≥ 65 61 10.43 40 12.13 1.16 (0.78–1.74) 31 11.21 1.07 (0.70–1.66)
Esophagus (150) < 65 65 2.50 36 2.73 1.09 (0.73–1.65) 29 2.52 1.01 (0.65–1.57)
≥ 65 147 25.41 80 24.51 0.96 (0.73–1.27) 74 26.81 1.05 (0.80–1.40)
Stomach (151) < 65 98 3.65 41 3.15 0.86 (0.60–1.25) 45 3.85 1.05 (0.74–1.51)
≥ 65 306 51.26 180 53.13 1.04 (0.86–1.25) 154 52.68 1.03 (0.85–1.25)
Rectum (154 excluding 154.3) < 65 50 1.91 27 2.12 1.11 (0.69–1.78) 24 2.07 1.08 (0.66–1.77)
≥ 65 136 22.52 76 22.54 1.00 (0.75–1.33) 93 32.41 1.44 (1.10–1.88)
Liver, gallbladder including < 65 46 1.78 37 2.80 1.57 (1.01–2.42) 18 1.47 0.82 (0.48–1.43)
bile ducts (155, 156) ≥ 65 133 22.31 75 22.20 1.00 (0.75–1.32) 82 28.66 1.28 (0.97–1.69)
Pancreas (157) < 65 127 4.86 75 5.64 1.16 (0.87–1.55) 60 5.11 1.05 (0.77–1.43)
≥ 65 326 54.98 191 57.64 1.05 (0.88–1.25) 210 73.33 1.33 (1.12–1.59)
Larynx (161) < 65 15 0.59 15 1.07 1.80 (0.87–3.70) 10 0.86 1.44 (0.64–3.23)
≥ 65 52 8.93 24 7.44 0.83 (0.51–1.35) 38 14.16 1.58 (1.04–2.41)
Prostate (185) < 65 82 3.02 55 3.78 1.25 (0.89–1.76) 54 4.30 1.42 (1.01–2.01)
≥ 65 1,286 206.47 781 224.38 1.09 (0.99–1.19) 754 253.04 1.23 (1.12–1.34)
Kidney, ureter (189, < 65 70 2.71 45 3.32 1.23 (0.84–1.79) 43 3.61 1.33 (0.91–1.95)
excluding 189.3) ≥ 65 202 34.08 102 30.70 0.90 (0.71–1.14) 86 30.16 0.88 (0.69–1.14)
Bladder, other urinary organs < 65 32 1.24 10 0.72 0.58 (0.29–1.20) 13 1.02 0.83 (0.43–1.58)
(188, 189.3) ≥ 65 274 44.36 137 39.46 0.89 (0.72–1.09) 116 39.68 0.89 (0.72–1.11)
Brain, other parts of nervous < 65 140 5.17 56 4.29 0.83 (0.61–1.13) 65 5.66 1.10 (0.81–1.47)
system (191, 192) ≥ 65 124 21.90 75 23.63 1.08 (0.81–1.44) 65 23.75 1.08 (0.80–1.47)
Thyroid (193) ≥ 65 6 1.02 7 2.02 1.99 (0.66–5.95) 8 2.58 2.54 (0.88–7.35)
Bone including jaw (170) < 65 12 0.46 7 0.53 1.16 (0.45–2.96) 10 0.92 2.00 (0.86–4.65)
≥ 65 7 1.17 5 1.43 1.22 (0.39–3.86) 6 2.11 1.80 (0.60–5.39)
Hodgkin disease (201) < 65 20 0.68 19 1.46 2.15 (1.14–4.07) ND – –
≥ 65 18 3.04 13 4.01 1.32 (0.64–2.70) 11 4.10 1.35 (0.63–2.86)
Leukemia (204–208, < 65 126 4.70 56 4.53 0.96 (0.70–1.32) 56 4.77 1.01 (0.74–1.39)
202.4, 203.1) ≥ 65 345 56.81 190 55.71 0.98 (0.82–1.17) 192 66.19  1.16 (0.98–1.39)
Secondary, site unspeciﬁed, < 65 146 5.54 81 6.16 1.11 (0.85–1.46) 48 4.00 0.72 (0.52–1.00)
not previously listed (152, 158, ≥ 65 433 71.67 250 75.72 1.06 (0.90–1.24) 176 61.58 0.86 (0.72–1.02)
159.2–159.9, 164.2–164.9)
All cancers (140–208) < 65 2,369 89.78 1,218 91.60 1.02 (0.95–1.09) 1,065 90.84 1.01 (0.94–1.09)
≥ 65 7,073 1184.10 3,987 1189.70 1.00 (0.97–1.04) 3,574 1243.80 1.05 (1.01–1.09)
Abbreviations: ICD-9, International Classiﬁcation of Diseases, 9th Revision (World Health Organization, Geneva); ND, not done (< 5 deaths reported per group). Comparison of grouped
counties based on tertiles of wheat acreage per county. Rates per 100,000 are age-adjusted and are calculated only if at least ﬁve deaths are reported in each of the two groups being
compared. The annual population-at-risk for combined counties with < 23,000, 23,000–110,999, and ≥ 111,000 acres of wheat for those < 65 years of age: 281,187, 123,286, and 106,711,
respectively; for those ≥ 65 years of age: 57,284, 32,182, and 27,708, respectively. are occupationally exposed to sunlight,
which is a known risk factor for melanoma
and eye cancer (25,30). 
A review of several case–control and
cohort studies investigating the effect of
herbicides (mostly phenoxy herbicides) on
cancer observed that herbicide exposure was
associated with increased risks for non-
Hodgkin lymphoma; soft-tissue sarcoma; can-
cer of the colon, nose, prostate, and ovary;
leukemia; and multiple myeloma (27).
A follow-up study based on a multicen-
ter registry of chlorophenoxy herbicide pro-
duction workers and sprayers created by the
International Agency for Research on
Cancer (IARC) was conducted; the study
included nearly 22,000 subjects with an
average follow-up of 22 years (6). Nearly
14,000 subjects had been involved in the
production of 2,4,5-T and were therefore
probably exposed to its contaminant
TCDD. Increased mortality (not statistically
significant unless otherwise noted) was
observed for the following sites: all cancers
(statistically significant), oral cavity and
pharynx, esophagus, rectum, peritoneum
and unspecific digestive organs, larynx, 
lung, other respiratory organs (statistically 
signiﬁcant), connective and soft tissue, non-
melanoma skin, female breast, male breast,
endometrium and uterus, prostate, testis,
other male genital organs, bladder, kidney
(statistically significant), thyroid, other
endocrine organs, ill-deﬁned and unspeciﬁed
neoplasms, non-Hodgkin lymphoma,
Hodgkin lymphoma, and multiple myeloma.
More than 7,500 workers had been involved
in the production of chlorophenoxy herbi-
cides excluding 2,4,5-T, and thus were not
likely to have been exposed to TCDD.
Increased mortality in this group was
observed for the following sites: colon, peri-
toneum and unspecified digestive organs,
nose and nasal sinuses, larynx, respiratory
organs excluding lung, bone, connective and
soft tissue, cervix uteri, endometrium and
uterus, prostate, testis, other male genital
organs, thyroid, other endocrine organs (sta-
tistically signiﬁcant), multiple myeloma, and
leukemia. Although exposures in the IARC
study (6) were better defined, the current
ecologic study with > 50 times more subjects
resulted in a higher number of statistically
signiﬁcant associations. 
Because of its high occurrence, prostate
cancer mortality in the current study is fur-
ther discussed in relation to other studies.
Farming has been associated with an
increased risk of this cancer (12,24,30,
31,33,38–42). Parker et al. (40) found a posi-
tive trend for risk of prostate cancer with years
of farming in an Iowa farming cohort study.
Other epidemiologic studies have provided
evidence that prostate cancer may be associat-
ed with race, lifestyle, environmental factors,
high animal fat intake, and may be hormonal
in origin (38,43,44). In a study of prostate
cancer mortality in Canadian farmers from
Manitoba, Saskatchewan, and Alberta,
Morrison et al. (41) observed a dose–response
effect for risk of prostate cancer mortality dur-
ing 1971–1987 with the number of acres
sprayed with herbicides (mostly chlorophe-
noxy herbicides) in 1970. In a meta-analysis
of studies on prostate cancer and farming,
Keller-Byrne et al. (42) concluded that hor-
monally active agricultural chemicals are most
likely responsible for the association between
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Table 8. Age-standardized cancer mortality rates and ratios for selected cancer sites for white women < 65 and ≥ 65 years of age, 1980–1989. 
Wheat acreage/county 
< 23,000 23,000–110,999 ≥ 111,000 
Cancer site (ICD-9) Age (years) n Rate n Rate SRR (CI) n Rate SRR (CI) 
Oral cavity including tongue < 65 7 0.26 6 0.43 1.65 (0.55–4.98) 9 0.78 2.97 (1.10–8.06)
(141,143–146, 148, 149) ≥ 65 30 3.25 18 3.64 1.12 (0.60–2.07) 18 4.73 1.45 (0.79–2.69)
Esophagus (150) < 65 8 0.31 ND – – 6 0.53 1.69 (0.58–4.89)
≥ 65 50 5.71 32 7.26 1.27 (0.80–2.02) 21 5.20 0.91 (0.54–1.55)
Stomach (151) < 65 33 1.26 24 1.85 1.47 (0.86–2.50) 34 3.01 2.39 (1.48–3.88)
≥ 65 207 22.53 103 20.23 0.90 (0.70–1.15) 91 21.80 0.97 (0.75–1.25)
Rectum (154 excluding 154.3) < 65 17 0.61 13 0.96 1.57 (0.76–3.26) 9 0.77 1.27 (0.56–2.86)
≥ 65 114 12.05 76 15.76 1.31 (0.96–1.78) 52 13.01 1.08 (0.77–1.52)
Liver, gallbladder including < 65 37 1.40 29 2.08 1.49 (0.91–2.43) 19 1.65 1.18 (0.68–2.07)
bile ducts (155, 156) ≥ 65 204 24.96 97 21.18 0.85 (0.66–1.09) 108 29.61 1.19 (0.93–1.51)
Pancreas (157) < 65 77 2.90 49 3.71 1.28 (0.89–1.84) 50 4.13 1.42 (0.99–2.04)
≥ 65 377 43.72 210 46.42 1.06 (0.89–1.27) 191 50.62 1.16 (0.97–1.39)
Cervix uteri (180) < 65 42 1.58 25 2.05 1.30 (0.79–2.14) 26 2.40 1.52 (0.93–2.49)
≥ 65 40 4.80 15 3.22 0.67 (0.36–1.26) 24 7.41 1.54 (0.92–2.60)
Ovary, fallopian tube, < 65 149 5.61 64 4.79 0.85 (0.63–1.15) 73 6.40 1.14 (0.86–1.51)
broad ligament (183) ≥ 65 362 46.56 182 44.54 0.96 (0.80–1.15) 157 46.55 1.00 (0.82–1.21)
Kidney, ureter (189,  < 65 50 1.85 20 1.55 0.84 (0.49–1.41) 22 1.81 0.98 (0.59–1.63)
excluding 189.3) ≥ 65 127 16.41 65 15.09 0.92 (0.68–1.25) 68 18.59 1.13 (0.83–1.54)
Bladder, other urinary organs < 65 11 0.39 8 0.54 1.37 (0.55–3.45) 6 0.52 1.33 (0.49–3.61)
(188, 189.3) ≥ 65 112 11.72 59 12.15 1.04 (0.75–1.44) 53 12.71 1.08 (0.77–1.53)
Brain, other parts of nervous < 65 90 3.28 41 3.01 0.92 (0.63–1.33) 42 3.79 1.16 (0.80–1.67)
system (191, 192) ≥ 65 99 13.31 53 13.43 1.01 (0.72–1.42) 53 15.37 1.15 (0.82–1.63)
Thyroid (193) ≥ 65 19 2.12 11 2.39 1.13 (0.52–2.44) 13 3.29 1.55 (0.74–3.26)
Bone including jaw (170) ≥ 65 12 1.52 5 1.01 0.67 (0.23–1.94) 7 1.72 1.14 (0.42–3.04)
Hodgkin disease (201) < 65 14 0.52 5 0.38 0.74 (0.26–2.09) ND – –
≥ 65 15 1.99 14 3.00 1.51 (0.71–3.21) 12 3.30 1.66 (0.76–3.61)
Leukemia (204–208, 202.4,  < 65 89 3.33 38 2.95 0.89 (0.60–1.30) 38 3.27 0.98 (0.67–1.44)
203.1) ≥ 65 284 31.30 145 30.90 0.99 (0.80–1.22) 108 28.07 0.90 (0.71–1.13)
Secondary, site unspeciﬁed, < 65 115 4.35 63 4.87 1.12 (0.82–1.53) 51 4.30 0.99 (0.71–1.38)
not previously listed ≥ 65 440 49.09 287 59.97 1.22 (1.04–1.43) 217 57.98 1.18 (1.00–1.40)
(152, 158, 159.2–159.9,
164.2–164.9)
All cancers (140–208) < 65 2,103 79.23 1,080 81.59 1.03 (0.96–1.11) 973 85.16 1.07 (1.00–1.16)
≥ 65 5,721 683.33 3,081 681.58 1.00 (0.95–1.04) 2,601 709.28 1.04 (0.99–1.09)
Abbreviations: ICD-9, International Classiﬁcation of Diseases, 9th Revision (World Health Organization, Geneva); ND, not done (< 5 deaths reported per group). Comparison of grouped
counties based on tertiles of wheat acreage per county. Rates per 100,000 are age-adjusted and are calculated only if at least ﬁve deaths are reported in each of the two groups being
compared. The average annual population-at-risk for combined counties with < 23,000, 23,000–110,999, and ≥ 111,000 acres of wheat: < 65 years of age: 273,995, 119,295, and 100,567,;
respectively; ≥ 65 years of age: 75,665, 40,905, and 33,538, respectively. prostate cancer and farming. Both 2,4-D and
MCPA, the exposure of interest in the current
study, and the potential contaminant, diox-
ins, are endocrine disruptors (1,42). In
addition, adjuvants used in the application of
2,4-D to spring wheat also have endocrine-
disrupting characteristics (45). In the IARC
occupational cohort, there was a slight, non-
statistically significant increase in prostate
cancer mortality (6). The combined results
from these previous investigations, in addi-
tion to those in the current ecologic study,
suggest a link between prostate cancer and
exposure to chlorophenoxy herbicides or
their contaminants.
Both non-Hodgkin lymphoma and soft-
tissue sarcoma have been associated with
exposure to chlorophenoxy herbicides
(2,5,9,46–49). The use of 2,4-D for lawn
care has been associated with malignant lym-
phoma in pet dogs, which is the equivalent
of canine non-Hodgkin lymphoma (50). No
increase in mortality from non-Hodgkin
lymphoma was observed in the current
study. Connective and soft-tissue sarcoma in
the current study was nonsignificantly
increased in women in counties with ≥
23,000 acres of wheat (Table 4).
Several cancers, especially prostate cancer,
have been on the rise for several decades in
the general population, mostly in the United
States and Western Europe (43,44,51,52).
The herbicides 2,4-D and MCPA, used since
the Second World War, are widely applied for
domestic use in many countries. Application
rates of herbicides for domestic use are often
higher than those for agricultural use (1).
Results from the current and other published
studies raise the question of whether
chlorophenoxy herbicides or their contami-
nants are involved in the increase of prostate
and other cancers in the general population. 
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